Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4779 | this study is non- interventional Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This study is an open trial designed specifically to address the need for evidence-based treatment delivered via telehealth to individuals that are currently struggling with mental health issues during the COVID-19 pandemic, with the overarching goal of helping residents of New York adversely impacted by the pandemic to effectively manage their anxiety, stress, and depression during this unprecedented time in human history.
Description: Mood and Anxiety Symptoms Questionnaire (MASQ)
Measure: Changes in Anxiety, Depression, and Distress Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Depression Anxiety Stress Scale (DASS)
Measure: Changes in Anxiety, Depression, and Distress Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Penn State Worry Questionnaire (PSWQ)
Measure: Changes in Worry Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Rumination-Reflection Questionnaire (RRQ)
Measure: Changes in Rumination Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Sheehan Disability Scale (SDS)
Measure: Changes in Functional Impairment Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Brief Multidimensional Students' Life Satisfaction Scale (BMSLSS)
Measure: Changes in Life Satisfaction Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Patient-Reported Outcomes Measurement Information System (PROMIS): Meaning and Purpose
Measure: Changes in Life Satisfaction Time: Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-UpDescription: Patient-Reported Outcomes Measurement Information System (PROMIS): Anxiety
Measure: Semi-Weekly Measures of Treatment Changes in Anxiety Time: Semi-weekly over the course of four weeksDescription: Patient-Reported Outcomes Measurement Information System (PROMIS): Depression
Measure: Semi-Weekly Measures of Treatment Changes in Depression Time: Semi-weekly over the course of four weeksDescription: Quick Inventory of Depressive Symptoms(QUIDS)
Measure: Semi-Weekly Measures of Treatment Changes in Depression Symptoms Time: Semi-weekly over the course of four weeksDescription: Distress Thermometer (DT)
Measure: Semi-Weekly Measures of Treatment Changes in Distress Time: Semi-weekly over the course of four weeksDescription: Brief Penn State Worry Questionnaire (PSWQ)
Measure: Semi-Weekly Measures of Treatment Changes in Worry Time: Semi-weekly over the course of four weeksDescription: Brief Rumination-Reflection Questionnaire (RRQ)
Measure: Semi-Weekly Measures of Treatment Changes in Rumination Time: Semi-weekly over the course of four weeksDescription: Emotion Regulation Questionnaire (ERQ)
Measure: Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation Time: Semi-weekly over the course of four weeksDescription: Experiences Questionnaire (EQ)
Measure: Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation Time: Semi-weekly over the course of four weeksDescription: The Attentional Control Scale (ACS)
Measure: Semi-Weekly Measures of Treatment Changes in Attentional Regulation Time: Semi-weekly over the course of four weeksDescription: Client Satisfaction Questionnaire (CSQ)
Measure: Satisfaction and Usability of Treatment Time: Post-Treatment (4-5 weeks after starting treatment)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports